Masamitsu Shimazawa
- Molecular Biology top 1%
- Ophthalmology top 0.2%
- Neurology top 0.2%
- Cellular and Molecular Neuroscience top 1%
- Cell Biology top 1%
- Co-authors
- Hideaki HaraKazuhiro TsurumaShinsuke NakamuraYoshimi NakajimaSatoshi MishimaYuta InokuchiToru IwamaYoshiki Kuse
- Topics
- Retinal Diseases and Treatments (79 papers)Retinal Development and Disorders (75 papers)Glaucoma and retinal disorders (58 papers)
- Cited by
- OphthalmologyNeurologyBiochemistry
- Partner nations
- JapanUnited StatesAustralia
In The Last Decade
Masamitsu Shimazawa
376 papers receiving 11.0k citations
Peers
Comparison fields: 5 of 159
- Molecular Biology 4.8k
- Ophthalmology 2.3k
- Neurology 1.7k
- Cellular and Molecular Neuroscience 1.2k
- Cell Biology 1.2k
Countries citing papers authored by Masamitsu Shimazawa
This map shows the geographic impact of Masamitsu Shimazawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masamitsu Shimazawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masamitsu Shimazawa more than expected).
Fields of papers citing papers by Masamitsu Shimazawa
This network shows the impact of papers produced by Masamitsu Shimazawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masamitsu Shimazawa. The network helps show where Masamitsu Shimazawa may publish in the future.
Co-authorship network of co-authors of Masamitsu Shimazawa
This figure shows the co-authorship network connecting the top 25 collaborators of Masamitsu Shimazawa. A scholar is included among the top collaborators of Masamitsu Shimazawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masamitsu Shimazawa. Masamitsu Shimazawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 1 | |
| 3 | 8 | |
| 4 | 7 | |
| 5 | 2 | |
| 6 | 3 | |
| 7 | 5 | |
| 8 | 6 | |
| 9 | 2 | |
| 10 | 12 | |
| 11 | 30 | |
| 12 | Donepezil, an anti-Alzheimer's disease drug has the neuroprotective effect on RGCs derived from familial glaucoma patients’ iPS cells. | 2 |
| 13 | The involvement of ATF4 and S-opsin in retinal photoreceptor cell damage induced by blue LED light. | 15 |
| 14 | 13 | |
| 15 | 18 | |
| 16 | 1 | |
| 17 | 12 | |
| 18 | 11 | |
| 19 | 122 | |
| 20 | 88 |
About Masamitsu Shimazawa
Masamitsu Shimazawa is a scholar working on Ophthalmology, Neurology and Biochemistry, having authored 382 papers that have together received 11.2k indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (79 papers), Retinal Development and Disorders (75 papers) and Glaucoma and retinal disorders (58 papers). The work is most often cited by research in Ophthalmology (2.3k citations), Neurology (1.7k citations) and Biochemistry (744 citations). Masamitsu Shimazawa has collaborated with scholars based in Japan, United States and Australia. Frequent co-authors include Hideaki Hara, Kazuhiro Tsuruma, Shinsuke Nakamura, Yoshimi Nakajima, Satoshi Mishima, Yuta Inokuchi, Toru Iwama, Yoshiki Kuse, Hiroshi Izuta and Shinichi Yoshimura. Their work appears in journals such as Journal of the American Chemical Society, PLoS ONE and Stroke.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.